Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis

Steroids

Volumn 78, Issue 2, 2013, Pages 161-170

  Yue, Wei ^a   Yager, James D ^a,b   Wang, Ji Ping ^a   Jupe, Eldon R ^a,c   Santen, Richard J ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c InterGenetics Incorporated   (United States)

Author keywords

Breast cancer; Catechol estrogen depurinating adduct; Catechol estrogens; Estrogen receptor; Estrogens; Genotoxicity

Indexed keywords

ANTIESTROGEN; AROMATASE INHIBITOR; ESTRADIOL; ESTROGEN RECEPTOR;

BREAST CARCINOGENESIS; CANCER PREVENTION; CELL FUNCTION; DISEASE ACTIVITY; ESTROGEN METABOLISM; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENOTOXICITY; HUMAN; REVIEW; STEM CELL;

BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; ESTRADIOL; FEMALE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MUTAGENS; RECEPTORS, ESTROGEN;

EID: 84871432401     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.11.001     Document Type: Review

References (62)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. A.M. Martin, and B.L. Weber Genetic and hormonal risk factors in breast cancer J Natl Cancer Inst 92 2000 1126 1135
3. P. Lichtenstein, N.V. Holm, P.K. Verkasalo, A. Iliadou, J. Kaprio, and M. Koskenvuo Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland N Engl J Med 343 2000 78 85
4. D. Thompson, and D. Easton The genetic epidemiology of breast cancer genes J Mammary Gland Biol Neoplasia 9 2004 221 236
5. N. Mavaddata, A.C. Antonioua, D.F. Eastona, and M. Garcia-Closasb Genetic susceptibility to breast cancer Mol Oncol 4 2010 174 191
6. P.L. Welcsh, and M.C. King BRCA1 and BRCA2 and the genetics of breast and ovarian cancer Hum Mol Genet 10 2001 705 713
7. T.R. Rebbeck, H.T. Lynch, S.L. Neuhausen, S.A. Narod, L. van't Veer, and J.E. Garber Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 2002 1616 1622
8. M. Clemons, and P.E. Goss Estrogen and the risk of breast cancer N Engl J Med 344 2001 276 285
9. B. Zumoff Does postmenopausal estrogen administration increase the risk of breast cancer? Contributions of animal, biochemical, and clinical investigative studies to a resolution of the controversy Proc Soc Exp Biol Med 217 1998 30 37
10. A.B. Hollingsworth, M.R. Lerner, S.A. Lightfoot, K.B. Wilkerson, J.S. Hanas, and P.B. McCay Prevention of DMBA-induced rat mammary carcinomas comparing leuprolide, oophorectomy, and tamoxifen Breast Cancer Res Treat 47 1998 63 70
11. M. Feinleib Breast cancer and artificial menopause: a cohort study J Natl Cancer Inst 41 1968 315 329
12. B.S. Hulka Epidemilologic analysis of breast and gynecologic cancers Prog Clin Biol Res 396 1997 17 29
13. T. Key, P. Appleby, I. Barnes, and G. Reeves Group EHaBCC. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 2002 606 616
14. R. Kaaks, S. Rinaldi, T.J. Key, F. Berrino, P.H.M. Peeters, and C. Biessy Postmenopausal serum androgens, oestrogens and breast cancer risk: the european prospective investigation into cancer and nutrition Endocr Relat Cancer 12 2005 1071 1082
15. J. Cuzick International-breast-cancer-intervention-study. A brief review of the international breast cancer intervention study (IBIS), the other current breast cancer prevention trials, and proposals for future trials Ann N Y Acad Sci 949 2001 123 133
16. S.R. Cummings, S. Eckert, K.A. Krueger, D. Grady, T.J. Powles, and J.A. Cauley The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple outcomes of raloxifene evaluation JAMA 281 1999 2189 2197
17. S. Martino, J.A. Cauley, E. Barrett-Connor, T.J. Powles, J. Mershon, and D. Disch Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene J Natl Cancer Inst 96 2004 1751 1761
18. P.E. Goss, J.N. Ingle, J.E. Alés-Martínez, A.M. Cheung, R.T. Chlebowski, and J. Wactawski-Wende Exemestane for breast-cancer prevention in postmenopausal women N Engl J Med 364 2011 2381 2391
19. A. Howell, J. Cuzick, M. Baum, A. Buzdar, M. Dowsett, and J.F. Forbes Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer Lancet 365 2005 60 62
20. Group TBIGB-C A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer N Engl J Med 353 2005 2747 2757
21. S. Preston-Martin, M.C. Pike, R.K. Ross, P.A. Jones, and B.E. Henderson Increased cell division as a cause of human cancer Cancer Res 50 1990 7415 7421
22. L.J. Hofseth, A.M. Raafat, J.R. Osuch, D.R. Pathak, C.A. Slomski, and S.Z. Haslam Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast J Clin Endocrinol Metab 84 1999 4559 4565
23. W.P. Bocchinfuso, W.P. Hively, J.F. Couse, H.E. Varmus, and K.S. Korach A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha Cancer Res 59 1999 1869 1876
24. T.R. Rebbeck, N.D. Kauff, and S.M. Domchek Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J Natl Cancer Inst 101 2009 80 87
25. S.R. Lakhani, M.J. Van De Vijver, J. Jacquemier, T.J. Anderson, P.P. Osin, and L. McGuffog The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2 J Clin Oncol 20 2002 2310 2318
26. W.D. Foulkes, K. Metcalfe, P. Sun, W.M. Hanna, H.T. Lynch, and P. Ghadirian Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type Clin Cancer Res 10 2004 2029 2034
27. A. Eisen, J. Lubinski, J. Klijin, P. Moller, H.T. Lynch, and K. Offit Brest cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study J Clin Oncol 23 2005 7491 7496
28. M.C. King, S. Wieand, K. Hale, M. Lee, T. Walsh, and K. Owens Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: national surgical adjuvant breast and bowel project (NSABP-P1) breast cancer prevention trial JAMA 286 2001 2251 2256
29. J.D. Yager, and R.J. Santen Mechanisms relating estrogens to breast cancer Transl Endocrinol Metab 3 2012 1 19
30. J. Russo, H.M. Lareef, Q. Tahin, Y.-F. Hu, C. Slater, and X. Ao 17β-Estradiol is carcinogenic in human breast epithelial cells J Steroid Biochem Mol Biol 80 2002 149 162
31. J. Russo, S.V. Fernandez, P.A. Russo, R. Fernbaugh, F.S. Sheriff, and H.M. Lareef 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells FASEB J 20 2006 1622 1634
32. J.D. Yager, and N.E. Davidson Estrogen carcinogenesis in breast cancer N Engl J Med 354 2006 270 282
33. E. Cavalieri, D. Chakravarti, J. Guttenplan, R. Jankowiak, P. Muti, and E. Rogan Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention Biochim Biophys Acta 1766 2006 63 78
34. Z. Zhao, W. Kosinska, M. Khmelnitsky, E.L. Cavalieri, E.G. Rogan, and D. Chakravarti Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB rat2 embryonic cells, and the mutational spectrum of 4-hydroxyestradiol Chem Res Toxicol 19 2006 475 479
35. J.G. Liehr Is estradiol a genotoxic mutagenic carcinogen? Endocr Rev 21 2000 40 54
36. S.V. Fernandez, I.H. Russo, and J. Russo Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells Int J Cancer 118 2006 1862 1868
37. L.Y. Kong, P. Szaniszlo, T. Albrecht, and J.G. Liehr Frequency and molecular analysis of hprt mutations induced by estradiol in Chinese hamster V79 cells Int J Oncol 17 2000 1141 1149
38. S.V. Fernandez, I.H. Russo, M. Lareef, B. Balsara, and J. Russo Comparative genomic hybridization of human breast epithelial cells transformed by estrogen and its metabolites Int J Oncol 26 2005 691 695
39. W. Yue, J.-P. Wang, Y. Li, P. Fan, G. Liu, and N. Zhang Effects of estrogen on breast cancer development: role of estrogen receptor independent mechanisms Int J Cancer 127 2010 1748 1757
40. E. Cavalieri, and E.G. Rogan Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer J Steroid Biochem Mol Biol 125 2011 169 180
41. N.W. Gaikwad, L. Yang, P. Muti, J.L. Meza, S. Pruthi, and J.N. Ingle The molecular etiology of breast cancer: evidence from biomarkers of risk Int J Cancer 122 2008 1949 1957
42. N.W. Gaikwad, L. Yang, S. Pruthi, J.N. Ingle, N. Sandhu, and E.G. Rogan Urine biomarkers of risk in the molecular etiology of breast cancer Breast Cancer: Basic Clin Res 3 2009 1 8
43. J.A. Lavigne, J.E. Goodman, T. Fonong, S. Odwin, P. He, and D.W. Roberts The effects of catechol-O-methyltransferase inhibition on estrogen metablolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells Cancer Res 61 2001 7488 7494
44. B.J. Fuhrman, C. Schairer, M.H. Gail, J. Boyd-Morin, X. Xu, and L.Y. Sue Estrogen metabolism and risk of breast cancer in postmenopausal women J Natl Cancer Inst 104 2012 326 339
45. H.L. Bradlow, R. Hershcopf, C. Martucci, and J. Fishman 16α-Hydroxylation of estradiol: a possible risk marker for breast cancer Ann N Y Acad Sci 464 1986 138 151
46. M. Zahid, E. Kohli, M. Saeed, E. Rogan, and E. Cavalieri The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity Chem Res Toxicol 19 2006 164 172
47. E. Cavalieri, K. Frenkel, J.G. Liehr, N.A. Boyd, R.A. Jong, and J.A. Cauley Estrogens as endogenous genotoxic agents-DNA adducts and mutations J Natl Cancer Inst Monogr 2000 2000 75 93
48. J.D. Yager Endogenous estrogens as carcinogens through metabolic activation J Natl Cancer Inst Monogr 27 2000 67 73
49. C.R. Jefcoate, J.G. Liehr, R.J. Santen, T.R. Sutter, J.D. Yager, and W. Yue Tissue-specific synthesis and oxidative metabolism of estrogens J Natl Cancer Inst Monogr 2000 2000 95 112
50. S. Singh, D. Chakravarti, J.A. Edney, R.R. Hollins, P.J. Johnson, and W.W. West Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma Oncol Rep 14 2005 1091 1096
51. S.K. Park, D.-S. Yim, K.-S. Yoon, I.-M. Choi, J.-Y. Choi, and K.-Y. Yoo Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk Breast Cancer Res Treat 88 2004 55 62
52. M.D. Ritchie, L.W. Hahn, N. Roodi, L.R. Railey, W.D. Dupont, and F.F. Parl Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer Am J Hum Genet 69 2001 138 147
53. D.A. Ralph, L.P. Zhao, C.E. Aston, S. Manjeshwar, T.W. Pugh, and D.C. DeFreese Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk Cancer 109 2007 1940 1948
54. K. Mitrunen, V. Kataja, M. Eskelinen, V.-M. Kosma, D. Kang, and S. Benhamou Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk Pharmacogenetics 12 2002 67 72
55. A.M. Dunning, C.S. Healey, P.D. Pharoah, M.D. Teare, B.A. Ponder, and D.F. Easton A systematic review of genetic polymorphisms and breast cancer risk Cancer Epidemiol Biomarkers Prev 8 1999 843 854
56. K. Mitrunen, and A. Hirvonen Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism Mutat Res 544 2003 9 41
57. P.S. Crooke, C. Justenhoven, H. Brauch, S. Dawling, N. Roodi, and K.S.P. Higginbotham Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction Cancer Epidemiol Biomarkers Prev 20 2011 1502 1515
58. F.F. Parl, S. Dawling, N. Roodi, and P.S. Crooke Estrogen metabolism and breast cancer Ann N Y Acad Sci 1155 2009 68 75
59. F.F. Parl, K.M. Egan, C. Li, and P.S. Crooke Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction Cancer Infom 7 2009 109 121
60. M.-L. Asselin-Labat, F. Vaillant, J.M. Sheridan, B. Pal, D. Wu, and E.R. Simpson Control of mammary stem cell function by steroid hormone signalling Nature 465 2010 798 802
61. P.A. Joshi, H.W. Jackson, A.G. Beristain, M.A. Di Grappa, P.A. Mote, and C.L. Clarke Progesterone induces adult mammary stem cell expansion Nature 465 2010 803 807
62. E.L. Cavalieri, E.G. Rogan, and D. Chakravarti Initiation of cancer and other diseases by catechol ortho-quinones: a unifying mechanism Cell Mol Life Sci 59 2002 665 681